Clinical relevance of an objective flow cytometry approach based on limit of detection and limit of quantification for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial

Using a multiparametric flow cytometry assay, we assessed the predictive power of a threshold calculated applying the criteria of limit of detection (LOD) and limit of quantitation (LOQ) in adult patients with acute myeloid leukemia. This was a post-hoc analysis of 261 patients enrolled in the GIMEM...

Descripción completa

Detalles Bibliográficos
Autores principales: Buccisano, Francesco, Palmieri, Raffaele, Piciocchi, Alfonso, Arena, Valentina, Maurillo, Luca, Del Principe, Maria-Ilaria, Paterno, Giovangiacinto, Irno-Consalvo, Maria-Antonietta, Ottone, Tiziana, Divona, Mariadomenica, Conti, Consuelo, Fraboni, Daniela, Lavorgna, Serena, Arcese, William, Voso, Maria Teresa, Venditti, Adriano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Acute Myeloid Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713557/
https://www.ncbi.nlm.nih.gov/pubmed/35295076
http://dx.doi.org/10.3324/haematol.2021.279777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713557/
https://www.ncbi.nlm.nih.gov/pubmed/35295076
http://dx.doi.org/10.3324/haematol.2021.279777

Ejemplares similares